MMHA 6452 Week 5 Conflict of Interest Case Analysis Example

A Trustee, a Spouse's Pharmacy and the 340B Contract: A Conflict of Interest Case Analysis at Westfall Community Health Center

Student Name

Walden University

MMHA 6452: Board Governance and Volunteer Management

Instructor Name

Month Day, Year

A Trustee, a Spouse's Pharmacy and the 340B Contract: A Conflict of Interest Case Analysis at Westfall Community Health Center

Facts

Westfall Community Health Center, an invented four-site nonprofit health center, participates in the federal 340B drug pricing program and dispenses discounted drugs to its patients through contract pharmacies. Its current contract pharmacy agreement expires in four months. Staff issued a request for proposals and received three responses, one of them from Elmstead Pharmacy, an independent pharmacy two blocks from the center's east site. The board must approve the new agreement at its meeting next month, on the recommendation of its Finance Committee.

Ms. R has served on the board for three years as a community member, not as a patient member. She sits on the Finance Committee. Her husband owns Elmstead Pharmacy outright. She has not disclosed the relationship in connection with this procurement, although her annual disclosure form, filed eleven months ago, lists her husband's ownership of the pharmacy. The Finance Committee meets in two weeks to review the three proposals. These facts are composite and illustrative.

The Interest

If Elmstead is selected, it would receive a dispensing fee for every 340B prescription it fills for Westfall patients, and likely new customers for non-340B purchases as well. The gain would go to Ms. R's husband directly and to Ms. R through her household. It would arrive through a specific decision, the board's approval of the contract pharmacy agreement, and through the committee recommendation that precedes it. The relationship is close and financial, which places it within almost any definition of a conflict of interest. The question is not whether a conflict exists but what Westfall's policy requires next.

Applying Westfall's Policy

Westfall's conflict of interest policy, GOV-03, is summarized here in its operative provisions.

Provision 2.1: "A director has a conflict of interest when the director, a member of the director's family, or an entity in which either holds a financial interest may benefit from a transaction or arrangement with the center." Family is defined to include a spouse. Elmstead is an entity in which Ms. R's spouse holds a financial interest, and the agreement is an arrangement with the center. The provision is met.

Provision 3.1: "A director shall disclose any actual or possible conflict to the chair before the board or a committee considers the matter." The annual disclosure form records the ownership, but it was filed before this procurement began and does not mention the agreement. The policy requires disclosure tied to the matter being considered. Ms. R has not yet made that disclosure, and the committee has not yet considered the proposals, so she can still comply.

Provision 3.2: "After disclosure, the interested director shall leave the meeting while the matter is discussed and shall not vote." This applies at both the Finance Committee and the board. It also reaches informal influence: a director who leaves the room but has already discussed the proposals with other committee members has not fully recused.

Provision 3.3: "The remaining directors shall determine whether the transaction is fair and in the center's best interest, and may approve it by a majority of disinterested directors." The policy does not bar Elmstead from being selected. It requires that the decision be made by disinterested directors on the merits.

Provision 4.1: "The minutes shall record the disclosure, the director's absence from discussion and vote, and the basis for the decision." This applies to both meetings.

Where the policy does not reach. GOV-03 says nothing about whether an interested director may help prepare the request for proposals or score responses. Ms. R did neither, according to staff, but the policy should say so. It is also silent on whether the board should seek an independent comparison of the three proposals when a director's family member is a bidder.

Disclosure and Recusal as a Sequence

The steps, in order, are as follows. First, the CEO or chair informs Ms. R that the Elmstead proposal triggers provision 3.1 and asks for a written disclosure before the Finance Committee meets. Second, Ms. R discloses in writing to the chair, and the chair informs the committee chair. Third, at the Finance Committee meeting, the disclosure is read into the record, Ms. R leaves before discussion of the proposals, and the minutes note the time she left and returned. Fourth, the committee evaluates the three proposals against the criteria in the request for proposals and records its reasons. Fifth, at the board meeting, the same disclosure, departure and recording occur, and the board votes with Ms. R absent. Sixth, the compliance officer files a copy of the disclosure and both sets of minutes with the procurement record.

Federal health center requirements reinforce this sequence. Health centers must maintain written standards of conduct covering conflicts of interest in procurement, including a bar on participation by anyone with a real or apparent conflict in selecting or administering a contract (Health Resources and Services Administration, 2018). Form 990 also has a question about regular monitoring and enforcement of the conflict policy (Internal Revenue Service, 2024), and these six steps leave exactly the paper trail that question presumes.

Residual Questions

Three questions remain that the board's counsel, not this analysis, should answer. First, whether the state's nonprofit statute adds requirements for transactions with a director's family member, such as a finding of fairness recorded in specific terms. Second, whether 340B program rules or the center's federal grant terms impose any additional procurement standard for contract pharmacy arrangements. Third, whether Ms. R should step off the Finance Committee for the remainder of the contract period, since the committee will review the pharmacy's performance and payments. These are legal and governance judgments with consequences the policy does not foresee.

Recommendation

The chair should ask Ms. R for a written disclosure now, before the Finance Committee meets, and the committee and board should follow the six-step sequence above. Elmstead's proposal should be evaluated on the same criteria as the others. If Elmstead is selected, the minutes should state why. The Governance Committee should amend GOV-03 to cover participation in preparing or scoring procurements and to require matter-specific disclosure even when an annual form exists. Loyalty does not require that conflicts never arise; it requires that they be handled openly so that interested directors do not shape decisions (Fremont-Smith, 2004). Handled this way, the board protects both the center and Ms. R.

References

Fremont-Smith, M. R. (2004). Governing nonprofit organizations: Federal and state law and regulation. Belknap Press of Harvard University Press.

Health Resources and Services Administration. (2018). Health center program compliance manual. U.S. Department of Health and Human Services.

Internal Revenue Service. (2024). Instructions for Form 990: Return of organization exempt from income tax. U.S. Department of the Treasury.